CrushSCI.com
74.7Average days
62.5Median days
18Fastest days
180Longest days
3692025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

37 days

Economic and Humanistic Burden of Cardiovascular Comorbidity in Kidney Failure: Findings from a Systematic Literature Review

Authors
Jürgen Floege; Nihar R. Desai; Wolfgang C. Winkelmayer; Kurt Neeser; Maria Vutcovici; Philipp A. Csomor; Maria Navarro; Marco SoroShow moreShow less
Affiliations
1. Department of Nephrology and Clinical Immunology, University Hospital Aachen, Aachen, Germany; 2. Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, USA; 3. Section of Nephrology, Baylor College of Medicine, Houston, USA; 4. Certara, Lörrach, Germany; 5. Certara, Montréal, Canada; 6. Global Medical Affairs, CSL Vifor, Glattbrugg, Switzerland; 7. Global Market Access, CSL Vifor, Rome, ItalyShow moreShow less
Source PDF DOI Publisher page
67 days

Sustainability Strategies and Practices in the Management of Chronic Kidney Disease: A Narrative Review

Authors
Saba Yousafzai; Haroon R. Mian; Caroline E. Stigant; Andrea J. MacNeill; Kasun Hewage; Rehan SadiqShow moreShow less
Affiliations
1. Life Cycle Management Laboratory, School of Engineering, The University of British Columbia, Okanagan, Kelowna, Canada; 2. Division of Nephrology, Island Health Authority, Department of Medicine, The University of British Columbia, Vancouver, Canada; 3. Department of Surgery, The University of British Columbia, Vancouver, CanadaShow moreShow less
Source PDF DOI Publisher page
18 days

Stepping up from ICS/LABA to FF/UMEC/VI in Patients with Uncontrolled Asthma: Outcomes from the 52-Week PERFORM Pragmatic Randomized Controlled Trial

Authors
John J. Oppenheimer; Erika Penz; Alan P. Baptist; Gabriel Garcia; Hiroyuki Nagase; Amila Poddar; Nicola Brown; David Slade; Jodie Crawford; Alison C. Moore; Stephen G. NoorduynShow moreShow less
Affiliations
1. University of Medicine and Dentistry of New Jersey-Rutgers, Newark, USA; 2. Division of Respirology and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, Canada; 3. Respiratory Research Center, University of Saskatchewan, Saskatoon, Canada; 4. Division of Allergy and Immunology, Henry Ford Health, Detroit, USA; 5. Respiratory Research Center, La Plata, Argentina; 6. Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan; 7. RII: Respiratory, GSK, Bangalore, India; 8. Clinical Sciences, Respiratory, GSK, London, UK; 9. Respiratory Clinical Research Unit, GSK, Collegeville, USA; 10. Development Biostatistics, GSK, London, UK; 11. Global Medical Affairs, General Medicines, GSK, London, UK; 12. Global Real-World Evidence, GSK, Mississauga, Canada; 13. Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, CanadaShow moreShow less
Source PDF DOI Publisher page
42 days

Baseline Choroidal Vascularity Index and Short-Term Choroidal Structural Change Following Faricimab in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration

Authors
Haidong Li; Liming Xu; Yun-e ZhaoShow moreShow less
Affiliations
1. National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, ChinaShow moreShow less
Source PDF DOI Publisher page
64 days

Evolution of Automated Insulin Delivery Devices in the Era of Artificial Intelligence: A Narrative Review

Authors
Jothydev Kesavadev; Tadej Battelino; Julia K. Mader; Viswanathan Mohan; Banshi Saboo; Arun Shankar; Anjana BasanthShow moreShow less
Affiliations
1. Jothydev’s Diabetes Research Centre, JDC Junction, Trivandrum, India; 2. UCH, University Medical Center Ljubljana, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; 3. Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; 4. Madras Diabetes Research Foundation (ICMR Collaborating Centre of Excellence) and Dr. Mohan’s Diabetes Specialities Centre (IDF Centre of Excellence in Diabetes Care), Chennai, India; 5. DiaCare, Ahmedabad, IndiaShow moreShow less
Source PDF DOI Publisher page
27 days

Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine

Authors
Theocharis Koufakis; Anastasios Tentolouris; Eleni Manthou; Lefteris Teperikidis; Andreas Mylonas; Kalliopi Kotsa; Michael DoumasShow moreShow less
Affiliations
1. Second Propedeutic Department of Internal Medicine, Hippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; 2. First Department of Propaedeutic Internal Medicine and Diabetes Center, School of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece; 3. School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; 4. Synthesa Inc., New York, USA; 5. Third Cardiology Department, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; 6. Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, GreeceShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does ADVANCES IN THERAPY take to review a manuscript?

As of 2026-11-18, CrushSCI has 20 complete review records for ADVANCES IN THERAPY. The fastest paper went from submission to acceptance in 18 days (Stepping up from ICS/LABA to FF/UMEC/VI in Patients with Uncontrolled Asthma: Outcomes from the 52-Week PERFORM Pragmatic Randomized Controlled Trial, received 2026-10-08, accepted 2026-10-26); the slowest took 180 days. The average is 74.7 days and the median is 62.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.